| Product Code: ETC320309 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines Contraceptive Drugs Market is projected to witness mixed growth rate patterns during 2025 to 2029. Starting at 9.41% in 2025, the market peaks at 13.09% in 2028, and settles at 11.21% by 2029.

Philippines's Contraceptive Drugs market is anticipated to experience a high growth rate of 12.85% by 2027, reflecting trends observed in the largest economy China, followed by India, Japan, Australia and South Korea.

With a CAGR of around 4.6%, the contraceptive drugs market in the Philippines has shown consistent growth due to increasing awareness of family planning and reproductive health.
The contraceptive drugs market in the Philippines is driven by factors such as increasing awareness about family planning, government initiatives to promote reproductive health, and the desire for better family planning options among the population.
The Philippines Contraceptive Drugs market faces intricate challenges that impact its accessibility and usage. A key challenge is the persistent societal stigma associated with contraceptive use. Cultural and religious factors influence public perceptions, leading to reluctance in openly discussing and adopting contraceptive methods. This stigma hampers education and awareness campaigns, making it challenging to disseminate accurate information about available options and their benefits. Additionally, inconsistent availability of a diverse range of contraceptive drugs, owing to regulatory restrictions and supply chain issues, limits the choices available to individuals and couples seeking effective family planning solutions.
The Philippines contraceptive drugs market has faced challenges in terms of supply chain disruptions and reduced access to healthcare services during the pandemic. The market for contraceptive drugs is expected to recover as healthcare services normalize.
Key players in the Philippines Contraceptive Drugs Market include: Pfizer Inc., Bayer AG, Allergan, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Janssen Pharmaceuticals, Inc., Church & Dwight Co., Inc., and Mylan N.V.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Contraceptive Drugs Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Contraceptive Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Contraceptive Drugs Market - Industry Life Cycle |
3.4 Philippines Contraceptive Drugs Market - Porter's Five Forces |
3.5 Philippines Contraceptive Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Contraceptive Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Contraceptive Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods in the Philippines |
4.2.2 Government initiatives to promote access to contraceptives and reproductive health services |
4.2.3 Growing population and rising demand for effective contraceptive drugs |
4.3 Market Restraints |
4.3.1 Cultural and religious barriers affecting the acceptance and usage of contraceptives |
4.3.2 Limited availability and accessibility of contraceptive drugs in rural areas |
4.3.3 Concerns about potential side effects and health risks associated with certain contraceptive drugs |
5 Philippines Contraceptive Drugs Market Trends |
6 Philippines Contraceptive Drugs Market, By Types |
6.1 Philippines Contraceptive Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Contraceptive Drugs Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Philippines Contraceptive Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.1.4 Philippines Contraceptive Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.5 Philippines Contraceptive Drugs Market Revenues & Volume, By Patches, 2021-2031F |
6.2 Philippines Contraceptive Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Philippines Contraceptive Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.3 Philippines Contraceptive Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.2.4 Philippines Contraceptive Drugs Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.5 Philippines Contraceptive Drugs Market Revenues & Volume, By Online Channel, 2021-2031F |
6.2.6 Philippines Contraceptive Drugs Market Revenues & Volume, By Public Channel & NGOs, 2021-2031F |
6.2.7 Philippines Contraceptive Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Contraceptive Drugs Market Import-Export Trade Statistics |
7.1 Philippines Contraceptive Drugs Market Export to Major Countries |
7.2 Philippines Contraceptive Drugs Market Imports from Major Countries |
8 Philippines Contraceptive Drugs Market Key Performance Indicators |
8.1 Number of individuals enrolled in family planning programs |
8.2 Percentage increase in the use of modern contraceptive methods |
8.3 Rate of adoption of long-acting reversible contraceptives (LARCs) |
9 Philippines Contraceptive Drugs Market - Opportunity Assessment |
9.1 Philippines Contraceptive Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Contraceptive Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Contraceptive Drugs Market - Competitive Landscape |
10.1 Philippines Contraceptive Drugs Market Revenue Share, By Companies, 2024 |
10.2 Philippines Contraceptive Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |